XOMA Royalty Corporation (XOMAP)

NASDAQ: XOMAP · Real-Time Price · USD · Preferred Stock
25.70
+0.05 (0.20%)
Aug 1, 2025, 4:00 PM - Market closed
0.20%
Market Cap296.42M
Revenue (ttm)42.91M
Net Income (ttm)-8.63M
Shares Out 11.97M
EPS (ttm)-0.73
PE Ration/a
Forward PEn/a
Dividend$2.16 (8.39%)
Ex-Dividend DateJul 3, 2025
Volume2,867
Open25.70
Previous Close25.65
Day's Range25.70 - 25.70
52-Week Range24.17 - 26.51
Beta0.93
Analystsn/a
Price Targetn/a
Earnings DateMay 7, 2025

About XOMAP

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 13
Stock Exchange NASDAQ
Ticker Symbol XOMAP
Full Company Profile

News

There is no news available yet.